Total medical devices industry M&A deals worth $26.81bn were announced in North America in Q1 2021, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.
Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 124.5% over the previous quarter and a rise of 70.9% when compared with the last four-quarter average of $15.69bn.
North America held an 87.33% share of the global medical devices industry M&A deal value that totalled $30.7bn in Q1 2021. With an 86.74% share and deals worth $26.63bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of deal activity, North America recorded 94 deals during Q1 2021, marking an increase of 30.56% over the previous quarter and a rise of 47.45% over the last four-quarter average. The US recorded 85 deals during the quarter.
North America medical devices industry M&A deals in Q1 2021: Top deals
The top five medical devices industry M&A deals accounted for 76.2% of the overall value during Q1 2021.
The combined value of the top five M&A deals stood at $20.42bn, against the overall value of $26.81bn recorded for the quarter.
The top five medical devices industry deals of Q1 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of 78% stake in Preventice
4) The $800m acquisition of Surgical Specialties by Corza Health
5) The merger of CM Life Sciences and Mount Sinai Genomics for $793m.